155 related articles for article (PubMed ID: 36844783)
1. Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G.
Al-Horani RA; Afosah DK; Kar S; Aliter KF; Mottamal M
RPS Pharm Pharmacol Rep; 2023 Jan; 2(1):rqad001. PubMed ID: 36844783
[TBL] [Abstract][Full Text] [Related]
2. Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G.
Aliter KF; Al-Horani RA
Med Chem; 2024 Apr; ():. PubMed ID: 38676528
[TBL] [Abstract][Full Text] [Related]
3. Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G.
Afosah DK; Fayyad RM; Puliafico VR; Merrell S; Langmia EK; Diagne SR; Al-Horani RA; Desai UR
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238630
[TBL] [Abstract][Full Text] [Related]
4. Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.
Al-Horani RA; Desai UR
J Med Chem; 2014 Jun; 57(11):4805-18. PubMed ID: 24844380
[TBL] [Abstract][Full Text] [Related]
5. Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.
Al-Horani RA; Gailani D; Desai UR
Thromb Res; 2015 Aug; 136(2):379-87. PubMed ID: 25935648
[TBL] [Abstract][Full Text] [Related]
6. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense.
Tausch L; Henkel A; Siemoneit U; Poeckel D; Kather N; Franke L; Hofmann B; Schneider G; Angioni C; Geisslinger G; Skarke C; Holtmeier W; Beckhaus T; Karas M; Jauch J; Werz O
J Immunol; 2009 Sep; 183(5):3433-42. PubMed ID: 19648270
[TBL] [Abstract][Full Text] [Related]
7. Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G.
Ledoux D; Merciris D; Barritault D; Caruelle JP
FEBS Lett; 2003 Feb; 537(1-3):23-9. PubMed ID: 12606025
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin Is an Allosteric Enhancer of the Proteolytic Activity of Cathepsin G.
Eipper S; Steiner R; Lesner A; Sienczyk M; Palesch D; Halatsch ME; Zaczynska E; Heim C; Hartmann MD; Zimecki M; Wirtz CR; Burster T
PLoS One; 2016; 11(3):e0151509. PubMed ID: 26986619
[TBL] [Abstract][Full Text] [Related]
9. Effective DNA inhibitors of cathepsin g by in vitro selection.
Gatto B; Vianini E; Lucatello L; Sissi C; Moltrasio D; Pescador R; Porta R; Palumbo M
Int J Mol Sci; 2008 Jun; 9(6):1008-1023. PubMed ID: 19325843
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice.
Wang J; Sukhova GK; Liu J; Ozaki K; Lesner A; Libby P; Kovanen PT; Shi GP
J Vasc Surg; 2015 Dec; 62(6):1615-24. PubMed ID: 25037606
[TBL] [Abstract][Full Text] [Related]
11. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
[TBL] [Abstract][Full Text] [Related]
12. Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.
Al-Horani RA; Ponnusamy P; Mehta AY; Gailani D; Desai UR
J Med Chem; 2013 Feb; 56(3):867-78. PubMed ID: 23316863
[TBL] [Abstract][Full Text] [Related]
13. A synthetic glycosaminoglycan mimetic blocks HSV-1 infection in human iris stromal cells.
Majmudar H; Hao M; Sankaranarayanan NV; Zanotti B; Volin MV; Desai UR; Tiwari V
Antiviral Res; 2019 Jan; 161():154-162. PubMed ID: 30481525
[TBL] [Abstract][Full Text] [Related]
14. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin G: roles in antigen presentation and beyond.
Burster T; Macmillan H; Hou T; Boehm BO; Mellins ED
Mol Immunol; 2010 Jan; 47(4):658-65. PubMed ID: 19910052
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.
Zou F; Lai X; Li J; Lei S; Hu L
Am J Transl Res; 2017; 9(11):5127-5137. PubMed ID: 29218110
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.
Ortega-Gomez A; Salvermoser M; Rossaint J; Pick R; Brauner J; Lemnitzer P; Tilgner J; de Jong RJ; Megens RT; Jamasbi J; Döring Y; Pham CT; Scheiermann C; Siess W; Drechsler M; Weber C; Grommes J; Zarbock A; Walzog B; Soehnlein O
Circulation; 2016 Oct; 134(16):1176-1188. PubMed ID: 27660294
[TBL] [Abstract][Full Text] [Related]
18. Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells.
Giese M; Turiello N; Molenda N; Palesch D; Meid A; Schroeder R; Basilico P; Benarafa C; Halatsch ME; Zimecki M; Westhoff MA; Wirtz CR; Burster T
Oncotarget; 2016 Nov; 7(46):74602-74611. PubMed ID: 27806341
[TBL] [Abstract][Full Text] [Related]
19. The down-regulation of cathepsin G in THP-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli.
Rivera-Marrero CA; Stewart J; Shafer WM; Roman J
Infect Immun; 2004 Oct; 72(10):5712-21. PubMed ID: 15385470
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin G and its Dichotomous Role in Modulating Levels of MHC Class I Molecules.
Burster T; Knippschild U; Molnár F; Zhanapiya A
Arch Immunol Ther Exp (Warsz); 2020 Aug; 68(4):25. PubMed ID: 32815043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
